Hedge Fund - SilverArc Capital
Akero Therapeutics Inc. (AKRO)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2025 - Q2 (2025-06-30) | $38,088,955 | 7.02% | 713,811 | $45.44 |
2 | 2025 - Q1 (2025-03-31) | $29,145,276 | 5.96% | 719,992 | $42.39 |
3 | 2024 - Q4 (2024-12-31) | $20,574,643 | 4.5% | 739,563 | $30.29 |
4 | 2024 - Q3 (2024-09-30) | $18,357,010 | 4.12% | 639,840 | $26.07 |
5 | 2024 - Q2 (2024-06-30) | $14,664,541 | 3.45% | 625,087 | $21.39 |
6 | 2024 - Q1 (2024-03-31) | $10,102,712 | 2.8% | 399,949 | $24.02 |
7 | 2023 - Q4 (2023-12-31) | $5,820,081 | 1.73% | 249,254 | $19.72 |
8 | 2023 - Q3 (2023-09-30) | $1,584,975 | 0.48% | 31,336 | $46.56 |
9 | 2023 - Q2 (2023-06-30) | $11,268,958 | 3.48% | 241,357 | $45.83 |
10 | 2023 - Q1 (2023-03-31) | $7,749,984 | 3.19% | 202,561 | $44.58 |
11 | 2022 - Q4 (2022-12-31) | $9,431,080 | 2.69% | 172,100 | $42.85 |
12 | 2022 - Q3 (2022-09-30) | $10,215,000 | 3.45% | 300,000 | $15.30 |
13 | 2022 - Q2 (2022-06-30) | $2,460,000 | 0.75% | 260,325 | $10.43 |
14 | 2021 - Q3 (2021-09-30) | $0 | 0% | 0 | $22.64 |
15 | 2021 - Q2 (2021-06-30) | $819,000 | 0.36% | 33,028 | $28.09 |
16 | 2021 - Q1 (2021-03-31) | $928,000 | 0.5% | 32,000 | $30.27 |
17 | 2020 - Q4 (2020-12-31) | $908,000 | 0.52% | 35,179 | $27.82 |
The displayed share prices are average quarterly stock market prices.